Gilead Agrees to Allow Generic Version of Groundbreaking H.I.V. Shot in Poor Countries
Many middle-income countries are left out of the deal, widening [...]
Biden Officials Stave Off Sticker Shock on Medicare Drug Premiums
Federal regulators spent billions of dollars to avoid a spike [...]
F.T.C. Accuses Drug Middlemen of Inflating Insulin Prices
The case takes aim at the major pharmacy benefit managers, [...]
The State That Chose to Cover Obesity Drugs for Its Poor, but Not Its Own Employees
The widespread use and enormous expense of blockbuster drugs like [...]
Acuerdan baja de precios para 10 medicamentos caros y comunes en EE. UU.
Los precios fueron posibles gracias a la Ley de Reducción [...]
U.S. Unveils Price Limits for 10 Costly or Common Medications
The Biden administration said it would have saved $6 billion [...]
2026 Prices for Drugs That Are Subject to Negotiations
The prices were made possible by the Inflation Reduction Act, [...]
Antisemitism on Campuses, Ivy and Beyond
Responses to a column by Bret Stephens. Also: Pharmacy benefit [...]
F.T.C. Says Middlemen Seem to Drive Up Drug Prices
In a report, the regulator sharply criticized pharmacy benefit managers, [...]
FDA Approves Donanemab, Eli Lilly’s New Drug for Early Alzheimer’s
The drug, Kisunla, made by Eli Lilly, is the latest [...]